$17.17
-0.22 (-1.27%)
As of May 9, 1:07 AM ET ·
Analyst Consensus
Buy
18
Analysts
High
Coverage
Buy 12 67%
Hold 5 28%
Sell 1 6%
Price Target
Analyst Price Target +615.3% upside
Low Target $69.38
Average Target $122.82
High Target $167.78
Current Price $17.17
Current
$17.17
Target
$122.82
$69.38 $122.82 avg $167.78
Scenario Analysis
Bear Case
$69.38
304.1%
Low target
Base Case
$122.82
+615.3%
Avg target
Bull Case
$167.78
+877.2%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$17.45
-1.6% from high
52-Week Low
$8.19
+109.6% from low
50-Day SMA
$13.14
+30.7% vs SMA
200-Day SMA
$10.55
+62.7% vs SMA
RSI (14)
87.6
Overbought
Target vs 52W High
$122.82
+603.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%